Home › combination
 

Keywords :   


Tag: combination

Combination tip drivers

2014-12-11 17:09:00| Electrical Construction & Maintenance

This line of combination-tip drivers is designed for maximum contact with the combination head screws read more

Tags: combination tip drivers

 

Interim Data from Proof-of-Concept Study of Mercks Investigational Hepatitis C Treatment Grazoprevir/Elbasvir in Combination with a Nucleotide Inhibitor (C-SWIFT study) Presented at The Liver Meeting

2014-11-10 00:53:00| Merck.com - Research & Development News

Dateline City: BOSTON Merck Plans to Initiate Phase 2 C-CREST Program to Evaluate Mercks Triple Combination of Grazoprevir/Elbasvir with MK-3682 (formerly IDX21437), a Novel Nucleotide Inhibitor, in Q1 2015 BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of interim data from the C-SWIFT study exploring the potential of a candidate triple-therapy regimen consisting of the fixed-dose combination of grazoprevir/elbasvir (MK-5172/MK-8742, MK-5172A), the companys investigational NS3/4A protease inhibitor and NS5A inhibitor, in combination with sofosbuvir, a nucleotide (NS5B) inhibitor for the treatment of chronic hepatitis C virus (HCV) infection. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: the data study presented

 
 

ZSW study finds combination of high-rate and low-temperature cycling increases hazard risks for Li-ion cells

2014-10-31 15:55:32| Green Car Congress

Tags: study combination cells increases

 

Nissan begins testing combination of LEAF EVs and LEAF to Home for grid demand response services

2014-10-16 16:55:37| Green Car Congress

Tags: home services response combination

 

Shire presses AbbVie to proceed with $55 billion combination of the 2 drugmakers

2014-10-15 14:55:20| Biotech - Topix.net

The drugmaker Shire wants AbbVie to stick with its roughly $55 billion acquisition bid, and it is reminding its U.S. counterpart of the hefty breakup fee it will receive if things don't work out. Shire's U.S.-traded shares shed about a quarter of their value before markets opened Wednesday and a day after AbbVie Inc. disclosed that it was reconsidering a deal it had fought for weeks to put together.

Tags: the combination billion proceed

 

Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] next »